Michigan Medicine
Avatar

Paradigm Shifts in Chronic Respiratory Failure

By Michigan Medicine FEATURING Philip Choi
By Michigan Medicine FEATURING Philip Choi
838 views
November 11, 2022
1 Comment
Login to view comments. Click here to Login

Featured Video

12:33
GSK

A Treatment Option for Chronic Rhinosinusitis With Nasal Polyps

Feat. C. Franzese

Featured Video

28:46
Boehringer Ingelheim

Systemic Sclerosis-Associated Interstitial Lung Disease: A Patient&#…

Feat. E. Volkmann

Related Content

AUTOPLAY
15:01
Insights from 2024 ATS Annual Meeting

ATS 2024 Insights: When Not All Is Lost - Reversal of Emphysema by R…

Feat. A. Racanelli
27:35
CHEST 2022 Coverage

Common Indoor Mold and Pulmonary Disease Associated With Them

Feat. S. Cherian
17:28
Antonio Anzueto

2023 COPD Guidelines Update

17:25
Temple Lung Center

GOLD Standards: What You Need to Know

Feat. G. Criner
16:13
3rd Advanced Lung Disease: Novel Therapies and Controversies Conference

Post COVID-19 Lung Complications

Feat. M. Padilla
17:18
3rd Advanced Lung Disease: Novel Therapies and Controversies Conference

Bronchiectasis: What's New and What's Next?

Feat. S. Devarajan
47:15
National Jewish Health

Updates in Pulmonary Function Testing

Feat. M. Mohning
16:39
Temple Lung Center

Access to Diagnostics and Medicines for COPD in Low or Middle-Income…

Feat. O. Beatrice Ozoh
41:37
McMaster University Department of Medicine

An Update on Parapneumonic Effusions

Feat. M. Chari
24:02
CHEST 2022 Coverage

Bronchoscopic Imaging for Interstitial Lung Disease

Feat. G. Zhi Cheng
24:36
Cleveland Clinic Respiratory Institute

Alpha-1 Antitrypsin Deficiency: State of the Art

Feat. J. Stoller
52:53
University of Colorado Department of Medicine

Interstitial Lung Disease in Rheumatic Diseases

Feat. M. Griffith
23:56
Aaron Baugh

ATS 2022: Before We Can Run - Racial Health Disparities in Lung Dise…

16:07
National Jewish Health

Triple Inhaled Therapy in COPD: Current Guidelines, Benefits/Risks, …

Feat. J. P. Woodrow
13:09
MedCram

Hydrocortisone Reduces Mortality by 48% in Severe Community-Acquired…

Feat. R. Seheult
40:32
McMaster University Department of Medicine

Short Course Antibiotic Therapy

Feat. B. Spellberg
23:33
CHEST 2022 Coverage

Inhaler Selection in COPD

Feat. D. Mahler
56:03
McMaster University Department of Medicine

Infectious Disease Update - What’s New in ID?

Feat. A. Kapoor
15:51
Temple Lung Center

Awareness of COPD in Low or Middle-Income Countries

Feat. S. Salvi
14:58
Temple Lung Center

The Role of Pulmonary Rehabilitation in ILD

Feat. S. Pourshadid